Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2018, Article ID 1543034, 9 pages
https://doi.org/10.1155/2018/1543034
Review Article

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis

1Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
2Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
4Canadian College of Naturopathic Medicine, Toronto, ON, Canada
5Department of Pharmacy, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada
6Department of Psychiatry, Ottawa Hospital, Ottawa, ON, Canada

Correspondence should be addressed to Chakrapani Balijepalli; moc.scimonocehtlaehnoisicerp@illapejilab.inaparkahc

Received 28 August 2017; Accepted 11 February 2018; Published 1 April 2018

Academic Editor: Luis San

Copyright © 2018 Chakrapani Balijepalli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Chakrapani Balijepalli, Eric Druyts, Michael J. Zoratti, et al., “Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis,” Schizophrenia Research and Treatment, vol. 2018, Article ID 1543034, 9 pages, 2018. https://doi.org/10.1155/2018/1543034.